Research Article

Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer

Table 5

Receiver-operating characteristic (ROC) curve analyses of cfDNA marker-based models to discriminate between healthy persons () and renal cancer patients ().

AUCStd. error value95% LCL95% UCL

Conc_qPCR0.804940.067710.001190.672230.93765
Conc_qPCR+APC0.918520.042058.61E − 060.83611.00094
Conc_qPCR+FHIT0.913580.048981.10E − 050.817591.00957
Conc_qPCR+RASSF10.881480.059865.00E − 050.764160.99881
Conc_qPCR+ APC+RASSF1101.06E − 0711
Conc_qPCR+APC+FHIT0.958020.030181.12E − 060.898881.01717
Conc_qPCR+RASSF1A+FHIT0.945680.045212.16E − 060.857081.03428
Conc_qPCR+APC+FHIT+RASSF1101.06E − 0711

Calculated by binary logistic regression using combination of different markers: concentration of cfDNA determined by qPCR (Conc_qPCR) and methylation marker genes (APC, FHIT, and RASSF1).